We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VRML market cap is 41.35M. The company's latest EPS is USD -1.6146 and P/E is -0.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.22M | 2.13M | 2.15M | 2.42M | 2.26M |
| Operating Income | -4.63M | -4.14M | -4.71M | -4.39M | -3.74M |
| Net Income | -5.22M | -3.09M | -4.63M | -3.53M | -3.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.54M | 4.65M | 6.81M | 8.18M | 9.15M |
| Operating Income | -15.28M | -17.98M | -32.6M | -32.77M | -18.85M |
| Net Income | -15.24M | -17.91M | -31.66M | -27.17M | -16.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.66M | 6.26M | 7.16M | 3.96M | 4.76M |
| Total Liabilities | 9.32M | 8.63M | 8.53M | 7.67M | 7.28M |
| Total Equity | -659k | -2.37M | -1.36M | -3.71M | -2.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 13.83M | 19.61M | 41.08M | 17.37M | 6.26M |
| Total Liabilities | 5.09M | 9.89M | 10.91M | 10.64M | 8.63M |
| Total Equity | 8.74M | 9.72M | 30.17M | 6.73M | -2.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.44M | -15.89M | -4.43M | -8.17M | -11.09M |
| Investing | -12k | -24k | -20k | -35k | -37k |
| Financing | 4.26M | 5.22M | 5.27M | 6.31M | 10.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.97M | -14.73M | -27.4M | -32.19M | -15.89M |
| Investing | -132k | -490k | -184k | -232k | -24k |
| Financing | 15.44M | 20.15M | 48.38M | 8.54M | 5.22M |
| Market Cap | 41.35M |
| Price to Earnings Ratio | -0.05 |
| Price to Sales Ratio | 0.09 |
| Price to Cash Ratio | 0.32 |
| Price to Book Ratio | -0.35 |
| Dividend Yield | - |
| Shares Outstanding | 10.34M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.25 (6.17%) |
| Company Name | Vermillion Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.aspirawh.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
